Eiko Lifesciences Q2 FY27 consolidated revenue Rs 1,772.02 lakh
For Q2 FY27, Eiko Lifesciences’ consolidated revenue was Rs 1,772.02 lakh and net profit Rs 156.37 lakh, up from Rs 1,167.17 lakh and Rs 128.47 lakh a year earlier.
Key takeaways
- Revenue from operations Rs 1,772.02 lakh vs Rs 1,167.17 lakh a year earlier.
- Net profit after tax Rs 156.37 lakh vs Rs 128.47 lakh in the year-ago quarter.
- Total revenue Rs 1,794.63 lakh vs Rs 1,193.28 lakh in Q2 last year.
- Profit before tax Rs 206.19 lakh vs Rs 171.17 lakh a year earlier.
- Basic EPS 0.93 vs 0.78 for the corresponding quarter of the previous year.
Q2 FY27 · consolidated
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 1,772.02 lakh | Rs 1,167.17 lakh | +51.8% |
| PAT | Rs 156.37 lakh | Rs 128.47 lakh | +21.7% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 8.82% of revenue, down 218 bps from 11.01%.
- Revenue rose 51.8% while total expenses rose 46.2%.
- Cost of materials accounted for Rs 306.24 lakh of the Rs 474.14 lakh rise in total expenses (64%).
- Cost of materials took 74.6% of revenue, against 87.0% a year earlier.
• Revenue from operations (consolidated) for the quarter ended 30.09.2026: Rs 1,772.02 lakh, vs Rs 1,167.17 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Other income (consolidated) for the quarter ended 30.09.2026: Rs 22.61 lakh, vs Rs 26.10 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Total revenue (consolidated) for the quarter ended 30.09.2026: Rs 1,794.63 lakh, vs Rs 1,193.28 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Cost of material consumed (consolidated) for the quarter ended 30.09.2026: Rs 1,322.10 lakh, vs Rs 1,015.86 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Changes in inventories of finished stock and work-in-progress (consolidated) for the quarter ended 30.09.2026: Rs 109.85 lakh, vs Rs (144.16) lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Employee benefits expense (consolidated) for the quarter ended 30.09.2026: Rs 20.32 lakh, vs Rs 13.74 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Depreciation and amortization expense (consolidated) for the quarter ended 30.09.2026: Rs 25.86 lakh, vs Rs 25.50 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Finance Cost (consolidated) for the quarter ended 30.09.2026: Rs 15.81 lakh, vs Rs 9.97 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Other expenses (consolidated) for the quarter ended 30.09.2026: Rs 96.36 lakh, vs Rs 105.24 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Total expenses (consolidated) for the quarter ended 30.09.2026: Rs 1,500.29 lakh, vs Rs 1,026.15 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Profit before Exceptional Items, Share of Profit in Equity Accounted Investee and Tax (consolidated) for the quarter ended 30.09.2026: Rs 204.34 lakh, vs Rs 167.13 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Profit before Share of Profit in Equity Accounted Investee and Tax (consolidated) for the quarter ended 30.09.2026: Rs 204.34 lakh, vs Rs 167.13 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Share of profit/(loss) in equity accounted investees (net) (consolidated) for the quarter ended 30.09.2026: Rs 1.86 lakh, vs Rs 4.04 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Profit / (Loss) before Tax (consolidated) for the quarter ended 30.09.2026: Rs 206.19 lakh, vs Rs 171.17 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Current tax (consolidated) for the quarter ended 30.09.2026: Rs 44.51 lakh, vs Rs 35.37 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Deferred tax (consolidated) for the quarter ended 30.09.2026: Rs 5.31 lakh, vs Rs 7.33 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Net Profit / (Loss) after tax (consolidated) for the quarter ended 30.09.2026: Rs 156.37 lakh, vs Rs 128.47 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Total comprehensive income after tax (consolidated) for the quarter ended 30.09.2026: Rs 156.37 lakh, vs Rs 128.47 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Profit for the period attributable to shareholders of the company (consolidated) for the quarter ended 30.09.2026: Rs 135.12 lakh, vs Rs 107.56 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Profit for the period attributable to non-controlling interests (consolidated) for the quarter ended 30.09.2026: Rs 21.25 lakh, vs Rs 20.91 lakh for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Paid up Equity Share Capital (consolidated) as at 30.09.2026: Rs 1,434.59 lakh, vs Rs 1,372.09 lakh as at 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Earnings Per Share – Basic (consolidated, not annualised) for the quarter ended 30.09.2026: 0.93, vs 0.78 for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
• Earnings Per Share – Diluted (consolidated, not annualised) for the quarter ended 30.09.2026: 0.78, vs 0.78 for the quarter ended 30.09.2025 (statement of financial results – consolidated statement of profit and loss).
For the quarter ended 30.09.2026, Eiko Lifesciences Limited reported higher consolidated revenue from operations and higher net profit after tax compared with the corresponding quarter a year earlier, according to the consolidated statement of profit and loss. Total revenue and total expenses both increased year-on-year, with cost of material consumed and changes in inventories moving up alongside employee benefits expense and finance cost.
The consolidated profit before tax and net profit after tax were higher than in the quarter ended 30.09.2025, while other income was slightly lower. Share of profit in equity accounted investees was positive in both periods but lower in the current quarter than a year earlier. Basic earnings per share rose compared with the same quarter of the previous year, while diluted earnings per share was unchanged on a year-on-year basis, as presented in the statement of financial results.
Track Eiko Lifesciences Ltd
Cruxal reads every Eiko Lifesciences Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
